Dominik Thor | President | Geneva College of Longevity Science Areas of collaboration Advertisement Education pathways for NADclinic-affiliated clinicians and clinical partners through relevant GCLS programmes Facilitating access to GCLS postgraduate and continuing professional education programmes for appropriately licensed healthcare professionals within the NADclinic ecosystem Joint webinars, clinical education sessions, masterclasses and thought-leadership activity around longevity and performance medicine A particular focus on education, clinical responsibility, evidence-based practice and regulatory awareness across emerging longevity and performance medicine interventions Clear referral pathways for clinicians introduced by NADclinic Group and PHI Peptides to GCLS programmes, subject to agreed commercial terms About NADclinic Group NADclinic Group is a global longevity and performance medicine platform supporting licensed clinicians, physicians, medical spas, professional sports organisations and healthcare partners
doi: 10.1038/cmi.2017.133
MASLD is now the leading cause of cirrhosis in the U.S., surpassing hepatitis C and alcohol overuse
Activation of the CB1 promotes the expression of lipogenic genes that are crucial for de novo fatty acid synthesis, increases oxidative stress, reduces antioxidant activity, and enhances fibrosis in the liver (15, 16)
